The Kayvan Keshari Lab
Research
Professor
The goal of our research program is to improve our biochemical understanding of cancer metabolism and use metabolic changes to develop non-invasive methods for diagnosis as well as approaches to treat cancer. Our work takes advantage of multi-modality methods at all scales, with a special focus in hyperpolarized magnetic resonance, allowing us the ability to bring these approaches to the clinic.
Featured News
Publications Highlights
Schild T, Wallisch P, Zhao Y, Wang YT, Haughton L, Chirayil R, Pierpont K, Chen K, Nunes-Violante S, Cross J, de Stanchina E, Thompson CB, Scheinberg DA, Perry JSA, Keshari KR. (2025) Metabolic engineering to facilitate anti-tumor immunity Cancer Cell. Mar 10;43(3):552-562.e9. doi: 10.1016/j.ccell.2025.02.004.
Patel S, Porcari P, Coffee E, Kim N, Berishaj M, Peyear T, Zhang G, Keshari KR. (2024) Simultaneous noninvasive quantification of redox and downstream glycolytic fluxes reveals compartmentalized brain metabolism. Science Advances Dec 20;10(51):eadr2058. doi: 10.1126/sciadv.adr2058.
Marin-Valencia I, Kocabas A, Rodriguez-Navas C, Miloushev VZ, González-Rodríguez M, Lees H, Henry KE, Vaynshteyn J, Longo V, Deh K, Eskandari R, Mamakhanyan A, Berishaj M, Keshari KR. (2024) Imaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiency Cell Metabolism Jun 4;36(6):1394-1410.e12. doi: 10.1016/j.cmet.2024.05.002
Keshari KR, Heller DA, Boltyanskiy R, Hricak H, Magaldi T, Overholtzer M. Engineering focusing on cancer. (2024) Cancer Cell Jul 8;42(7):1138-1141. doi: 10.1016/j.ccell.2024.04.013.
Pigliapochi R, Peyear T, Ruan T, Keshari KR. (2024) Hyperpolarized Nano-NMR Platform for Quantification of Mass Limited Samples. Analytical Chemistry. Jul 22:10.1021/acs.analchem.4c02378. doi: 10.1021/acs.analchem.4c02378
People
Kayvan R. Keshari, PhD
Fred Lebow Chair at MSK
Professor
- Biochemist and Bioengineer Kayvan Keshari explores changes in cancer metabolism to develop advanced imaging techniques and cancer therapeutics.
- BA, University of California, Berkeley
- PhD, University of North Carolina Chapel Hill
- [email protected]
- Email Address
- View physician profile
- Physician profile
Members
- University of Chicago: Physics, BS
- Mathematics, BA
- Yale University: Physics, PhD
- AB, Princeton University
- MD, PhD, Diagnostic Radiology Residency and Neuroradiology Fellowship, Columbia University
- University of Texas at Arlington: Bachelors of Science in Biochemistry
- Loma Linda University, Medical Degree
- BA, Oberlin College
- PhD, Weill Cornell Medical College
- PhD, Imperial College London, Bsc, Leeds University
- BA, University of Cambridge
- PhD, University of Cambridge
Achievements
- 2012 Pathway Independent Award
- 2012 Junior Fellow, International Society of Magnetic Resonance in Medicine
- 2019 NIH Rising Stars
- 2020 Distinguished Investigator, American Academy of Radiology and Biomedical Research
- 2024 Fellow, World Molecular Imaging Society
- 2025 Fellow, American Institute for Medical and Biological Engineering
Lab News & Events
Upcoming event
Publishing in Nature Biomedical Engineering
Memorial Sloan Kettering Cancer Center
Rockefeller Research Laboratories
430 East 67th Street
Room RRL-116
New York, NY 10065
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Career Opportunities
Get in Touch
-
Lab Head Email
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Kayvan R. Keshari discloses the following relationships and financial interests:
-
Atish Technologies, Inc.
Equity; Intellectual Property Rights -
GE Healthcare
Professional Services and Activities -
Imaginostics, Inc.
Equity
-
Mi2 Holdings LLC
Equity; Professional Services and Activities (Uncompensated) -
NVision Imaging Technologies GmbH
Equity; Professional Services and Activities
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].